Doxorubicin Cardiomyopathy
- 11 December 2009
- journal article
- review article
- Published by S. Karger AG in Cardiology
- Vol. 115 (2), 155-162
- https://doi.org/10.1159/000265166
Abstract
Established doxorubicin cardiomyopathy is a lethal disease. When congestive heart failure develops, mortality is approximately 50%. Extensive research has been done to understand the mechanism and pathophysiology of doxorubicin cardiomyopathy, and considerable knowledge and experience has been gained. Unfortunately, no effective treatment for established doxorubicin cardiomyopathy is presently available. Extensive research has been done and is being done to discover preventive treatments. However an effective and clinically applicable preventive treatment is yet to be discovered.Keywords
This publication has 58 references indexed in Scilit:
- The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic LeukemiaThe New England Journal of Medicine, 2004
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- Essential role of GATA-4 in cell survival and drug-induced cardiotoxicityProceedings of the National Academy of Sciences of the United States of America, 2004
- Congestive heart failure in patients treated with doxorubicinCancer, 2003
- Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytesJournal of the American College of Cardiology, 2003
- Anthracycline-Induced Suppression of GATA-4 Transcription Factor: Implication in the Regulation of Cardiac Myocyte ApoptosisMolecular Pharmacology, 2003
- Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemiaAnnals of Hematology, 2002
- Vanadate Induces p53 Transactivation through Hydrogen Peroxide and Causes ApoptosisOnline Journal of Public Health Informatics, 2000
- Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.2000
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973